It is suggested that, in SAS patients, downregulation of Cd38, Ryr2, and Fkbp12.6 may decrease the function of the Cd38–cADPR signaling in cardiomyocytes, leading to the failure of cardiac functions. The gene discussed is RYR2; the disease is SATB2 associated disorder.